This inventor holds 4 USPTO granted patents. Top assignees: Schering Aktiengesellschaft, Schering Akitiengesellschaft. Active years: 1998-2001.
Company Filing History:
Years Active: 1998-2001
Title: Klaus Stockemann: Innovator in Contraceptive Solutions
Introduction
Klaus Stockemann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of contraceptive technology, holding a total of 4 patents. His innovative work focuses on developing new methods for female birth control, emphasizing demand-oriented solutions.
Latest Patents
One of Stockemann's latest patents is a combination contraceptive. This invention relates to a combination product that consists of individual dosage units of a competitive progesterone antagonist and sequentially provided individual dosage units of a compound with gestagenic action. It is designed for the production of contraceptives based on the inhibition of implantation, specifically targeting receptivity inhibition. Another significant patent is for a competitive progesterone antagonist for demand-oriented female birth control. This invention describes the novel use of dissociated competitive progesterone antagonists for creating a pharmaceutical agent that can be used regardless of the point in the menstrual cycle. The dosage unit is intended to be administered on a one-time basis, with a dosage that is below the ovulation-inhibiting dosage.
Career Highlights
Throughout his career, Klaus Stockemann has worked with prominent companies, including Schering Aktiengesellschaft. His experience in the pharmaceutical industry has allowed him to develop groundbreaking contraceptive solutions that address the needs of women.
Collaborations
Some of his notable coworkers include Kristof Chwalisz and Karin Schmidt-Gollwitzer. Their collaboration has contributed to the advancement of contraceptive technologies.
Conclusion
Klaus Stockemann's innovative work in contraceptive solutions has made a significant impact in the field. His patents reflect a commitment to improving women's health and providing effective birth control options.